【血脂EP1】LDL不是只看數字：急診醫師圖解斑塊形成與破裂

One of the most frequently circled words on health check reports is LDL, often referred to as "bad cholesterol." But LDL doesn't immediately clog blood vessels upon its appearance. The real danger lies in its entry into the blood vessel wall, where it undergoes oxidation, inflammation, and macrophage phagocytosis, eventually forming atherosclerotic plaques. This first episode in our blood lipid series takes an emergency room physician to understand LDL from the perspective of clinical myocardial infarction and stroke: It's not just a simple fat number, but one of the most crucial players in cardiovascular risk management. 📌 Key takeaways from this episode: Understanding what LDL is: LDL is not just a mass of fat, but a lipoprotein particle with an outer layer, a core, and the ApoB-100 identifier. Understanding the process of atherosclerosis: From LDL entering the blood vessel wall, oxidation, macrophage phagocytosis, to foam cell and plaque formation. Understanding the Plaque Rupture Crisis: What truly causes acute myocardial infarction and ischemic stroke is often not the gradual narrowing of the plaque, but rather the sudden rupture and subsequent blood clot formation. Mastering the Risk Stratification Concept: Why do LDL control targets differ for low-risk, medium-risk, high-risk, and very high-risk groups? Understanding the Logic of Lipid-Lowering Therapy: From statins and zetimibe to PCSK9 inhibitors, understand how they help reduce LDL and the risk of cardiovascular events. Key Timeline for this Episode: 00:00:00 - What is LDL (Bad Cholesterol)? 00:03:40 - The First Stage of Vascular Collapse: Penetrating Walls 00:04:55 - The Second Stage of Vascular Collapse: Oxidative Deterioration 00:06:02 - The Third Stage of Vascular Collapse: Formation of Foam Cells and Necrotic Plaques 00:07:12 - The Fatal Moment: Plaque Rupture Triggers Myocardial Infarction or Stroke 00:08:21 - How Low Should LDL Be? The Higher the Cardiovascular Risk, the Stricter the Standards 00:09:37 - Three Major Weapons for Lowering Blood Lipids (Statins, Ezetimibe, PCSK9 Inhibitors) 00:10:45 - Residual Risk: Achieving Targets Does Not Equal Absolute Safety; Beware of Inflammatory Reactions and Lp(a) ⚠️ Disclaimer: This video is for medical education purposes only and should not replace a doctor's diagnosis, treatment, or individualized advice. Each person's blood lipid targets should be determined based on age, medical history, diabetes, kidney disease, cardiovascular disease history, and overall risk assessment. If you have abnormal blood lipids or feel unwell, please seek help from a professional doctor.